| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.07 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.076 | 0.07 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.07 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.07 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.08 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.12 | 0.08 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.08 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.08 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.08 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.08 |